|
|
|
News for Food and Drug Administration (FDA)News > FDAListings 21 - 30 of 657:
SparVax(TM) Regulatory Strategy Submitted to FDA by PharmAthene
A biodefense company developing medical countermeasures against biological and chemical threats PharmAthene, Inc announced that the Company has submit...
Samsca tablets treating Hyponatremia gets FDA approval
Samsca tablets (tolvaptan) to treat hyponatremia, an abnormally low concentration of sodium in the blood have been approved by the U.S. Food and Drug ...
Consumers Alerted by FDA to Recall of Water-Based Face Paints
The consumers are being constantly advised by the Food and Drug Administration to stop using certain cosmetic “Face Paint” items labeled as distribute...
Under Consent Verdict Dietary Supplements Worth $1.3 Million Condemned and Forfeited to the United States
The U.S. District Court for the Eastern District of Michigan, Southern Division, entered a consent decree that condemns and forfeits to the United Sta...
Drug for Treating Aggressive Brain Cancer Gets FDA’s Approval
The U.S. Food and Drug Administration gives its approval to Avastin (bevacizumab) to treat patients with glioblastoma multiforme (GBM) when this form ...
FY 2010 Budget of President for FDA Endows Considerably in Food and Medical Product Safety
A budget of $3.2 billion is being requested by the U.S. Food and Drug Administration to shield and promote the public health as part of the President’...
Fanapt Tablets to Treat Schizophrenia Approved by FDA
The U.S. Food and Drug Administration (FDA) announced that it has approved a new manufacturing facility used to produce influenza virus vaccines. The ...
Boxed Warning for All Botulinum Toxin Products Entailed by FDA
Incited by reports of serious adverse events, the U.S. Food and Drug Administration today announced that safety label changes, including a boxed warni...
Consumers Warned by FDA to Halt the Use of Hydroxycut Products
Consumers are being warned by the U.S. Food and Drug Administration to right away stop using Hydroxycut products by Iovate Health Sciences Inc., of Oa...
Supplementary Labeling for Over-the-Counter Pain Relievers and Fever Reducers Needed by FDA to Help Consumers Use Products Safely
A final rule that requires manufacturers of over-the-counter (OTC) pain relievers and fever reducers to revise their labeling to include warnings abou... |
|
|
Privacy Policy | Terms & Conditions | Support | Directory Links | Contact Us | Site Map | Home Copyright © 2007-2010 ComplianceHome.com. A SUPREMUS GROUP venture. All rights reserved. |